GLP-1 Coverage Guide is a private website. We are not Medicare, the Centers for Medicare & Medicaid Services (CMS), or any government agency, and we are not affiliated with or endorsed by them.
Text size:

Extension tracker: the program's end date, watched closely

Short answer: Status as of July 21, 2026: the Medicare GLP-1 Bridge ends December 31, 2027, and no extension or successor has been announced. KFF's assessment is blunt — there is currently 'no clear path forward' for Medicare GLP-1 weight-loss coverage after 2027. We update this page whenever the facts change.

Program facts last verified against CMS: July 21, 2026

Program timeline: launched July 1, 2026; Open Enrollment windows fall 2026 and fall 2027; program ends December 31, 2027.July 1, 2026Program startsYou are hereOpen Enrollment ’26Oct 15 – Dec 7Open Enrollment ’27Last one before the endDec 31, 2027Program ends — no successor announced
Every month you wait is a $50 month you can’t get back — the end date is fixed, your start date isn’t.

What we're tracking, and why the history matters

The program has already been restructured once: it launched as a stopgap after CMS shelved the BALANCE Model's Medicare component (its planned successor) when too few Part D plans signed up, and its window was extended from an original six months to the current eighteen. Read correctly, that extension was a symptom of the successor's failure — not evidence CMS intends permanence.

The signals that would matter, in rough order of significance: a CMS announcement extending the demonstration or rebooting BALANCE's Part D component; statutory movement in Congress on the long-debated Treat and Reduce Obesity Act approach (which would authorize coverage permanently); the demonstration's own results, which CMS will evaluate for cost and outcomes; and drug-price dynamics — significantly cheaper GLP-1s change the federal math that has always been the obstacle. We check CMS announcements weekly and stamp every update.

How to plan around the uncertainty

Plan on the program ending on schedule and treat anything better as upside. Concretely: start sooner rather than later (every month is a $50 month you can't get back), have the post-2027 conversation with your prescriber before it's urgent, and know your personal fallback — the Part D path if a routing diagnosis develops, manufacturer self-pay pricing otherwise. Our what-happens-after-2027 guide walks the scenarios.

Take the 2-minute eligibility check →

Common questions

Has any extension been proposed?

As of our last verification, no formal extension of the demonstration has been announced by CMS. This page's date stamp is the tell — we update it when that changes.

Didn't the program already get extended once?

Its window was lengthened from six to eighteen months in April 2026 — but that reflected the BALANCE Model's postponement, not a commitment to continue. Treating it as a durability signal would be a mistake.

What's the single most likely path to coverage continuing?

Honest answer: unknowable. The candidates are a demonstration extension, a BALANCE reboot, or congressional action — each with real obstacles, chiefly federal cost. Plan on the end date.

Related

Program-fact sources: CMS — Medicare GLP-1 Bridge · KFF